These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36602274)

  • 21. Accuracy of acute levodopa challenge for clinical prediction of sustained long-term levodopa response as a major criterion for idiopathic Parkinson's disease diagnosis.
    Merello M; Nouzeilles MI; Arce GP; Leiguarda R
    Mov Disord; 2002 Jul; 17(4):795-8. PubMed ID: 12210878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Performance of the Movement Disorders Society criteria for prodromal Parkinson's disease: A population-based 10-year study.
    Mahlknecht P; Gasperi A; Djamshidian A; Kiechl S; Stockner H; Willeit P; Willeit J; Rungger G; Poewe W; Seppi K
    Mov Disord; 2018 Mar; 33(3):405-413. PubMed ID: 29436728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protocol of a single group prospective observational study on the diagnostic value of 3T susceptibility weighted MRI of nigrosome-1 in patients with parkinsonian symptoms: the N3
    Schwarz ST; Xing Y; Naidu S; Birchall J; Skelly R; Perkins A; Evans J; Sare G; Martin-Bastida A; Bajaj N; Gowland P; Piccini P; Auer DP
    BMJ Open; 2017 Dec; 7(12):e016904. PubMed ID: 29247084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The evolution of diagnosis in early Parkinson disease. Parkinson Study Group.
    Jankovic J; Rajput AH; McDermott MP; Perl DP
    Arch Neurol; 2000 Mar; 57(3):369-72. PubMed ID: 10714663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic accuracy of apparent diffusion coefficient and 123I-metaiodobenzylguanidine for differentiation of multiple system atrophy and Parkinson's disease.
    Umemura A; Oeda T; Hayashi R; Tomita S; Kohsaka M; Yamamoto K; Sawada H
    PLoS One; 2013; 8(4):e61066. PubMed ID: 23613784
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of a Thai Parkinson's Disease Screening Tool and the Prevalence of Parkinsonism and Parkinson's Disease, Based on a Community Survey in Bangkok.
    Muangpaisan W; Siritipakorn P; Assantachai P
    Neuroepidemiology; 2017; 49(1-2):74-81. PubMed ID: 28877525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accuracy of clinical diagnosis of Parkinson disease: A systematic review and meta-analysis.
    Rizzo G; Copetti M; Arcuti S; Martino D; Fontana A; Logroscino G
    Neurology; 2016 Feb; 86(6):566-76. PubMed ID: 26764028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical validation of Movement Disorder Society-recommended diagnostic criteria for Parkinson's disease with dementia.
    Barton B; Grabli D; Bernard B; Czernecki V; Goldman JG; Stebbins G; Dubois B; Goetz CG
    Mov Disord; 2012 Feb; 27(2):248-53. PubMed ID: 22162144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parkinsonism in essential tremor cases: A clinicopathological study.
    Rajput AH; Rajput EF; Bocking SM; Auer RN; Rajput A
    Mov Disord; 2019 Jul; 34(7):1031-1040. PubMed ID: 31180613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sensitivity and Specificity of Diagnostic Criteria for Progressive Supranuclear Palsy.
    Ali F; Martin PR; Botha H; Ahlskog JE; Bower JH; Masumoto JY; Maraganore D; Hassan A; Eggers S; Boeve BF; Knopman DS; Drubach D; Petersen RC; Dunkley ED; van Gerpen J; Uitti R; Whitwell JL; Dickson DW; Josephs KA
    Mov Disord; 2019 Aug; 34(8):1144-1153. PubMed ID: 30726566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sensitivity of Sniffer Dogs for a Diagnosis of Parkinson's Disease: A Diagnostic Accuracy Study.
    Gao CQ; Wang SN; Wang MM; Li JJ; Qiao JJ; Huang JJ; Zhang XX; Xiang YQ; Xu Q; Wang JL; Liu ZH; Wang JG; Chen ZH; Hu PA; Song Z; Gu SJ; Zhang RX; Lei LF; Zhan KB; Long YT; Zhang Y; Ye M; Zhong Z; Liu YB; Zhang C; He ZM; Fang X; Peng JG; Wang CY; Xu H; Xia BH; Shen L; Tang BS; Zheng CW; Li YA; Guo JF
    Mov Disord; 2022 Sep; 37(9):1807-1816. PubMed ID: 36054272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effectiveness analysis of the Parkinson's KinetiGraph and clinical assessment in the management of Parkinson's disease.
    Chaudhuri KR; Hand A; Obam F; Belsey J
    J Med Econ; 2022; 25(1):774-782. PubMed ID: 35593687
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic accuracy of Magnetic Resonance Parkinsonism Index in differentiating progressive supranuclear palsy from Parkinson's disease and controls in Indian patients.
    Sankhla CS; Patil KB; Sawant N; Gupta S
    Neurol India; 2016; 64(2):239-45. PubMed ID: 26954800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ancillary investigations to diagnose parkinsonism: a prospective clinical study.
    Aerts MB; Esselink RA; Abdo WF; Meijer FJ; Drost G; Norgren N; Janssen MJ; Borm GF; Bloem BR; Verbeek MM
    J Neurol; 2015 Feb; 262(2):346-56. PubMed ID: 25381460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute Levodopa Challenge Test in Patients with de novo Parkinson's Disease: Data from the DeNoPa Cohort.
    Schade S; Sixel-Döring F; Ebentheuer J; Schulz X; Trenkwalder C; Mollenhauer B
    Mov Disord Clin Pract; 2017; 4(5):755-762. PubMed ID: 30363372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy-Parkinsonism From Parkinson's Disease.
    Quattrone A; Bianco MG; Antonini A; Vaillancourt DE; Seppi K; Ceravolo R; Strafella AP; Tedeschi G; Tessitore A; Cilia R; Morelli M; Nigro S; Vescio B; Arcuri PP; De Micco R; Cirillo M; Weis L; Fiorenzato E; Biundo R; Burciu RG; Krismer F; McFarland NR; Mueller C; Gizewski ER; Cosottini M; Del Prete E; Mazzucchi S; Quattrone A
    Mov Disord; 2022 Jun; 37(6):1272-1281. PubMed ID: 35403258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of Prodromal Parkinson's Disease as Defined by MDS Research Criteria among Elderly Patients Undergoing Colonoscopy.
    Skorvanek M; Ladomirjakova Z; Han V; Lesko N; Feketeova E; Jarcuskova D; Repkova B; Spisak P; Urbancikova Z; Vargova A; Gombosova L; Zakuciova M; Veseliny E; Trebuna F; Mechirova E; Gdovinova Z
    J Parkinsons Dis; 2017; 7(3):481-489. PubMed ID: 28387681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormal metabolic brain network associated with Parkinson's disease: replication on a new European sample.
    Tomše P; Jensterle L; Grmek M; Zaletel K; Pirtošek Z; Dhawan V; Peng S; Eidelberg D; Ma Y; Trošt M
    Neuroradiology; 2017 May; 59(5):507-515. PubMed ID: 28386687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and validation of the automated imaging differentiation in parkinsonism (AID-P): a multicentre machine learning study.
    Archer DB; Bricker JT; Chu WT; Burciu RG; McCracken JL; Lai S; Coombes SA; Fang R; Barmpoutis A; Corcos DM; Kurani AS; Mitchell T; Black ML; Herschel E; Simuni T; Parrish TB; Comella C; Xie T; Seppi K; Bohnen NI; Müller ML; Albin RL; Krismer F; Du G; Lewis MM; Huang X; Li H; Pasternak O; McFarland NR; Okun MS; Vaillancourt DE
    Lancet Digit Health; 2019 Sep; 1(5):e222-e231. PubMed ID: 33323270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accuracy of MDS-UPDRS section IV for detecting motor fluctuations in Parkinson's disease.
    Raciti L; Nicoletti A; Mostile G; Bonomo R; Dibilio V; Donzuso G; Sciacca G; Cicero CE; Luca A; Zappia M
    Neurol Sci; 2019 Jun; 40(6):1271-1273. PubMed ID: 30737581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.